Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zaia Ventures is a biotechnology venture studio based in Pasadena, California, focused on the creation and development of next-generation biologics companies. Founded by the leadership team of Xencor, the firm utilizes deep expertise in protein engineering to identify and incubate high-impact therapeutic opportunities. Zaia Ventures provides the necessary infrastructure, including seed capital and strategic management, to advance early-stage scientific concepts toward clinical validation. The studio primarily targets the development of novel protein-based modalities to address complex diseases in oncology and other therapeutic areas. By operating at the intersection of academic innovation and industrial drug discovery, Zaia Ventures streamlines the path to commercializing breakthrough biologics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zaia Ventures.